Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

NCT05838560 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Treatment Resistant Depression
Aging, Premature

Interventions

DRUG: Dasatinib
DRUG: quercetin

Sponsor

Washington University School of Medicine

Collaborators

UConn Health